Profil
Roni H Amiel is the founder of Pinscriptive, Inc. He is currently the Chief Executive Officer at Fibronostics Pte Ltd.
He was previously the Chief Executive Officer at Fibronostics US, Inc.
Aktive Positionen von Roni H Amiel
Unternehmen | Position | Beginn |
---|---|---|
Fibronostics Pte Ltd.
Fibronostics Pte Ltd. Information Technology ServicesTechnology Services Fibronostics Pte Ltd. develops and commercializes non-invasive diagnostic tests. It specializes in hepatology, nephrology, and metabolic conditions. The firm's products include LiverFACT and LiverFAST. The company is headquartered in Singapore. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Roni H Amiel
Unternehmen | Position | Ende |
---|---|---|
Fibronostics US, Inc.
Fibronostics US, Inc. Packaged SoftwareTechnology Services Fibronostics US, Inc. operates healthcare technology company, which develops algorithms to detect disease and monitor progression. The firm provides platform that develops non-invasive algorithm based diagnostics to improve treatment outcomes, facilitate screening of specific diseases and help prognosis in various chronic conditions. The company was founded in 2015 and is headquartered in Orlando, FL. | Vorstandsvorsitzender | - |
Pinscriptive, Inc.
Pinscriptive, Inc. Data Processing ServicesTechnology Services Pinscriptive, Inc. operates as a data analytics platform to identify the clinically effective specialty medications for individual patients. It delivers evidence backed and value based decision support to payers, such as health plans, PBMs, employers, and governments, physicians, specialty biopharmaceutical manufacturers, and patients seeking to make appropriate specialty drug decision. The company was founded by Mark Lelinski and Roni H. Amiel and is headquartered in San Juan Capistrano, CA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Pinscriptive, Inc.
Pinscriptive, Inc. Data Processing ServicesTechnology Services Pinscriptive, Inc. operates as a data analytics platform to identify the clinically effective specialty medications for individual patients. It delivers evidence backed and value based decision support to payers, such as health plans, PBMs, employers, and governments, physicians, specialty biopharmaceutical manufacturers, and patients seeking to make appropriate specialty drug decision. The company was founded by Mark Lelinski and Roni H. Amiel and is headquartered in San Juan Capistrano, CA. | Technology Services |
Fibronostics US, Inc.
Fibronostics US, Inc. Packaged SoftwareTechnology Services Fibronostics US, Inc. operates healthcare technology company, which develops algorithms to detect disease and monitor progression. The firm provides platform that develops non-invasive algorithm based diagnostics to improve treatment outcomes, facilitate screening of specific diseases and help prognosis in various chronic conditions. The company was founded in 2015 and is headquartered in Orlando, FL. | Technology Services |
Fibronostics Pte Ltd.
Fibronostics Pte Ltd. Information Technology ServicesTechnology Services Fibronostics Pte Ltd. develops and commercializes non-invasive diagnostic tests. It specializes in hepatology, nephrology, and metabolic conditions. The firm's products include LiverFACT and LiverFAST. The company is headquartered in Singapore. | Technology Services |